These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19903497)

  • 41. DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge.
    Kask AS; Chen X; Marshak JO; Dong L; Saracino M; Chen D; Jarrahian C; Kendall MA; Koelle DM
    Vaccine; 2010 Nov; 28(47):7483-91. PubMed ID: 20851091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1.
    Toka FN; Suvas S; Rouse BT
    J Virol; 2004 Dec; 78(23):13082-9. PubMed ID: 15542660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Infective and inactivated filamentous phage as carriers for immunogenic peptides.
    Samoylova TI; Norris MD; Samoylov AM; Cochran AM; Wolfe KG; Petrenko VA; Cox NR
    J Virol Methods; 2012 Jul; 183(1):63-8. PubMed ID: 22575687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity.
    Lauterbach H; Ried C; Epstein AL; Marconi P; Brocker T
    J Gen Virol; 2005 Sep; 86(Pt 9):2401-2410. PubMed ID: 16099897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A mucosal vaccination approach for herpes simplex virus type 2.
    Tirabassi RS; Ace CI; Levchenko T; Torchilin VP; Selin LK; Nie S; Guberski DL; Yang K
    Vaccine; 2011 Jan; 29(5):1090-8. PubMed ID: 21134447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system.
    Cattamanchi A; Posavad CM; Wald A; Baine Y; Moses J; Higgins TJ; Ginsberg R; Ciccarelli R; Corey L; Koelle DM
    Clin Vaccine Immunol; 2008 Nov; 15(11):1638-43. PubMed ID: 18784341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunocontraception: Filamentous Bacteriophage as a Platform for Vaccine Development.
    Samoylova TI; Braden TD; Spencer JA; Bartol FF
    Curr Med Chem; 2017 Nov; 24(35):3907-3920. PubMed ID: 28901276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune response and cytokine production following immunization with experimental herpes simplex virus 1 (HSV-1) vaccines.
    Durmanová V; Sapák M; Kosovský J; Rezuchová I; Kúdelová M; Buc M; Rajcáni J
    Folia Microbiol (Praha); 2008; 53(1):73-83. PubMed ID: 18481222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunogenicity and protective effect of a DNA construct encoding certain neutralizing epitopes of herpes simplex virus type-1 glycoprotein B.
    Bamdad T; Roostaee MH; Sadeghizadeh M; Mahboudi F; Kazemnejad A; Soleimanjahi H
    Folia Biol (Praha); 2005; 51(4):109-13. PubMed ID: 16180546
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peptide vaccination is superior to genetic vaccination using a recombineered bacteriophage λ subunit vaccine.
    Thomas BS; Nishikawa S; Ito K; Chopra P; Sharma N; Evans DH; Tyrrell DL; Bathe OF; Rancourt DE
    Vaccine; 2012 Feb; 30(6):998-1008. PubMed ID: 22210400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Novel Molecular Design for a Hybrid Phage-DNA Construct Against DKK1.
    Khalili S; Rasaee MJ; Bamdad T; Mard-Soltani M; Asadi Ghalehni M; Jahangiri A; Pouriayevali MH; Aghasadeghi MR; Malaei F
    Mol Biotechnol; 2018 Nov; 60(11):833-842. PubMed ID: 30182325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibacterial application of engineered bacteriophage nanomedicines: antibody-targeted, chloramphenicol prodrug loaded bacteriophages for inhibiting the growth of Staphylococcus aureus bacteria.
    Vaks L; Benhar I
    Methods Mol Biol; 2011; 726():187-206. PubMed ID: 21424451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Construction, identification, and immunogenic assessments of an HSV-1 mutant vaccine with a UL18 deletion.
    Wang L; Aoli Wang Q; Jin F; Fang S; Luo F; Wu Y; Li F; Liu J; Wang Y; Jin J; Liao X; Ren Z; Wang Y
    Acta Virol; 2018; 62(2):164-171. PubMed ID: 29895157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Murine response to DNA encoding herpes simplex virus type-1 glycoprotein D targeted to the liver.
    Rogers JV; Hull BE; Fink PS; Chiou HC; Bigley NJ
    Vaccine; 2000 Feb; 18(15):1522-30. PubMed ID: 10618550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of Recombinant HSV-Based Vaccine Vectors.
    Voellmy R; Bloom DC; Vilaboa N; Feller J
    Methods Mol Biol; 2017; 1581():55-78. PubMed ID: 28374243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide.
    van Houten NE; Zwick MB; Menendez A; Scott JK
    Vaccine; 2006 May; 24(19):4188-200. PubMed ID: 16488517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Humoral immune responses against gonadotropin releasing hormone elicited by immunization with phage-peptide constructs obtained via phage display.
    Samoylov A; Cochran A; Schemera B; Kutzler M; Donovan C; Petrenko V; Bartol F; Samoylova T
    J Biotechnol; 2015 Dec; 216():20-8. PubMed ID: 26456116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles.
    Ju Z; Sun W
    Drug Deliv; 2017 Nov; 24(1):1898-1908. PubMed ID: 29191048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The development of inovirus-associated vector vaccines using phage-display technologies.
    Stern Z; Stylianou DC; Kostrikis LG
    Expert Rev Vaccines; 2019 Sep; 18(9):913-920. PubMed ID: 31373843
    [No Abstract]   [Full Text] [Related]  

  • 60. In vivo gene delivery and expression by bacteriophage lambda vectors.
    Lankes HA; Zanghi CN; Santos K; Capella C; Duke CM; Dewhurst S
    J Appl Microbiol; 2007 May; 102(5):1337-49. PubMed ID: 17448169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.